A detailed history of Ameritas Investment Partners, Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,034 shares of FLGT stock, worth $43,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,034
Previous 2,034 -0.0%
Holding current value
$43,039
Previous $44,000 11.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$26.74 - $40.81 $11,845 - $18,078
443 Added 27.84%
2,034 $54,000
Q2 2021

Aug 06, 2021

BUY
$66.8 - $100.45 $30,460 - $45,805
456 Added 40.18%
1,591 $147,000
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $8,713 - $14,640
281 Added 32.9%
1,135 $59,000
Q2 2020

Aug 05, 2020

BUY
$8.89 - $18.28 $7,592 - $15,611
854 New
854 $14,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $640M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.